Home » Healthcare » Pharmaceuticals » Antibody Cocktail Market

Antibody Cocktail Market By Type (Monovalent Antibody and Polyvalent Antibody), By Indication (COVID-19, Cancer, and HIV) Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the report

How are the major segments performing in the Antibody Cocktail market?

In 2022, the monovalent antibody segment will accommodate the largest market share because regulatory bodies approve more items.
In 2022, the COVID-19 segment was anticipated to hold a major share of the global antibody cocktail market because additional strategies, such as agreements, are being used.
In 2022, the hospital pharmacies segment will dominate the global market owing to a larger inflow of patients presenting a wider range of cardiovascular disorders.

What is the Market Size of Antibody Cocktail regarding value?

The global antibody cocktail market is anticipated to grow at a substantial CAGR of 10.9% in the upcoming years. The global antibody cocktail industry was estimated to be worth USD 2.2 billion in 2022 and was expected to be worth USD 4.5 billion by 2028.

Which region dominated the Antibody Cocktail market?

In 2022, the North American region was anticipated to hold a prominent share in the global antibody cocktail market. Due to the rising need for various applications, including bulk antibody cocktails, medication delivery systems, catheters, cannulas, and other specialized applications (smoke evacuation tubing and peristaltic pump tubing), the market is expanding on a regional basis. The expansion of healthcare accessibility and the quickly rising demand for minimally invasive medical procedures further contribute to the market’s expansion.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

How US Market is Performing in the Antibody Cocktail market?

In 2022, the United States was anticipated to hold a prominent share in the global antibody cocktail market. Furthermore, the U.S. has retained its R&D tax credit at a low level, increasing the market demand for antibody cocktails. The number of older adults in the area is growing at an alarming rate; nevertheless, because of social security payments made by the government, America and Canada have the oldest populations in the best economic health.

How is the economy impacting the global Antibody Cocktail growth?

Rising inflation prices shook the worldwide economy after the outbreak. According to multiple research, the IMF warned in late October that more than a third of the world’s economy might collapse in 2023. Russia’s unofficial invasion of Ukraine caused years of turmoil and insecurity. This was Europe’s largest post-WWII fierce battle.

What is the competitive environment of the Antibody Cocktail market?

Important market participants use various growth methods, including geographic expansion and the introduction of new products, to increase their market share. They also expand brand awareness, and their already strong product offers to acquire a competitive advantage in the market. The market’s leading companies are also concentrating on creating and obtaining regulatory approval for antibody cocktail medicines, which will further fuel market expansion throughout the forecast period. For instance, the U.S. Food and Drug Administration granted Lilly, a pharmaceutical company, emergency use authorization in February 2021. The Drug Administration has approved using an antibody cocktail that combines the antibodies bamlanivimab and etesevimab to treat mild to moderate COVID-19 in patients 12 years of age and older at high risk for developing severe COVID-19.

Executive Summary

What are the key trends in the Antibody Cocktail market?

Throughout the projection period, the rising prevalence of infectious disorders, such as COVID-19, is anticipated to fuel market expansion.
Rising product approvals by regulatory agencies are anticipated throughout the projection period to fuel market expansion.

How did Antibody Cocktails Help Patients with COVID-19 (With a Case Study)

Presently, a trial was conducted a double-blind, randomized, placebo-controlled trial (Phase 1-3) of a cocktail (REGN-COV2) consisting of two fully human, neutralizing monoclonal antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in non-hospitalized patients with Covid-19 to prevent the emergence of treatment-resistant mutant virus. Patients were prospectively assessed at baseline for the endogenous immune response against SARS-CoV-2 and then randomly allocated (1:1:1) to receive either placebo, 2.4 g of REGN-COV2, or 8.0 g of REGN-COV2 (serum antibody–positive or serum antibody–negative). The percentage of patients who had at least one medically attended visit due to Covid-19 by day 29 and the time-weighted average change in viral load from baseline (day 1) through day seven were considered important end goals. All of the patients were checked for risks. Two hundred seventy-five patients’ data are presented. The time-weighted average change in viral load from day 1 through day 7 was 0.56 log10 copies per milliliter (95% confidence interval [CI]: 1.02 to 0.11) among patients who were serum antibody-negative at baseline and 0.41 log10 copies per milliliter (95% CI: 0.71 to 0.10) in the overall trial population. Patients who were serum antibody-negative at baseline were more likely to have at least one medically attended visit than those in the placebo group or the combined REGN-COV2 dosage groups (difference, nine percentage points; 95% CI, 29 to 11).

Which are the key investments by the Antibody Cocktail market players?

A few well-established firms and several medium-sized players dominate the market. To achieve a competitive edge in the market, major strategic activities are being undertaken by industry participants, such as product releases. For instance, Iptacopan, a Novartis investigational oral drug designed to treat paroxysmal nocturnal hemoglobinuria, recently reported its Phase II data in June 2021. (PNH). The study found that during the 12-week course of iptacopan monotherapy treatment, there were no unexpected safety problems. The majority of patients had their hemoglobin levels recover quickly and steadily without the need for transfusions. In August 2020, Johnson & Johnson and Momenta Pharmaceuticals Inc. reached a formal deal for nearly US$ 6.5 billion. Momenta Pharmaceuticals Inc is leading the industry in developing innovative therapies for immune-mediated illnesses.

Some major players in the antibody cocktail market are Cipla Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Zydus Cadila, AstraZeneca, Aridis Pharmaceuticals Inc., Immunome Inc., Celltrion Healthcare Co., Ltd.. and Eli Lilly and Company among others.

What are the Major Driving Factors for the Antibody Cocktail Market?

It is projected that the increased prevalence of several infectious diseases, including COVID-19, will drive market expansion during the duration of the forecast. On February 8, 2022, the World Health Organization Coronavirus (COVID-19) dashboard showed that the coronavirus was responsible for over 396,558,014 cases and 5,745,032 fatalities (COVID-19). Over the projected period, the global market for antibody cocktails is anticipated to increase due to the rising frequency of diseases like cancer and the subsequent efforts made by major companies and scientists to find a safe and effective treatment option to combat the condition. For instance, the World Health Organization reported on February 3, 2022, that cancer was a top cause of mortality internationally, accounting for about 10 million fatalities in 2020, or roughly one in six deaths globally. The market for antibody cocktails is expected to grow over the forecast period due to regulatory bodies increasingly authorizing goods for antibody cocktail therapy.

What are the Major Risks for the Antibody Cocktail Market?

The primary barriers to expanding the global market for antibody cocktails are the high cost of drugs and tight regulatory requirements for product approval. For instance, the REGEN-COV (Casrivimab and Imdevimab) antibody cocktail treatment from the biotechnology business Regeneron Pharmaceuticals Inc. costs US$ 2,100 per dosage in the US, US$ 2,000 per dosage in Germany, and US$ 820 per dosage in India.

Which is the key Indication in the Antibody Cocktail market?

The COVID-19 market sector was the most dominant in 2021, with the biggest market share, due to the widespread use of various techniques, including agreements. For instance, the biotechnology company Regeneron Pharmaceuticals Inc. announced in September 2021 a new agreement in which the United States Departments of Health and Human Services (HHS) and Defense (DOD) will purchase 1.4 million additional doses of REGEN-COV (casirivimab and imdevimab) for the treatment of COVID-19 patients.

How is the Antibody Cocktail market performing in regions?

Asia Pacific market is anticipated to witness the fastest global antibody cocktail market growth during the forecast period. In addition, the expansion of the market in the area is boosted by the rising availability of healthcare and the burgeoning interest in medical treatments that involve just a small amount of tissue disruption. The increasing number of people belonging to the middle class in China and India drives up the need for procedures that are only minimally invasive. Along with an increase in people’s interest in taking care of older people at home using straightforward and uncomplicated items, there has been a development in the field of more advanced medical equipment that is more effective.

What is the regulatory landscape for the Antibody Cocktail market?

The dominant Omicron subvariants in the United States are not anticipated to be responsive to anti-SARS-CoV-2 mAbs. The COVID-19 Treatment Guidelines Panel (the Panel) advises against using them to treat or prevent COVID-19. However, laboratory research has shown that anti-SARS-CoV-2 mAb efficacy against various subvariants and variations might vary significantly.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the major players planning for the future of the Antibody Cocktail market?

Due to multiple competitors, the market is consolidated and expected to experience intenser rivalry. The competition among these firms has increased due to major players investing extensively in research and development activities to incorporate cutting-edge technologies in antibody cocktails. For instance, in July 2021, pilot research employing a combination of the antibody drugs Casirvimab and Imdevimab to treat COVID-19 was successful, according to the Brihanmumbai Municipal Corporation (BMC). Only 0.5% of patients required oxygen after using this medicine combination, according to the BMC, and the fatality rate was reduced by 70%. A hospital stay of 13 to 14 days was required before the delivery of this antibody cocktail therapy; this period was reduced to 5 to 6 days.

REPORT ATTRIBUTE	DETAILS
Antibody Cocktail Market by Volume	No
Antibody Cocktail Market by Value	Yes
Antibody Cocktail Market, Tornado Analysis	Yes
Antibody Cocktail Market, STAR Analysis	Yes
Antibody Cocktail Market, SRC Analysis	Yes
Antibody Cocktail Market, Import-Export Data	Yes (On Demand)
Antibody Cocktail Market Pricing Analysis	Yes (On Demand)
Antibody Cocktail Market Segment Analysis	By Type (Monovalent Antibody and Polyvalent Antibody) By Indication (COVID-19, Cancer, and HIV) Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
Antibody Cocktail Market, Regional Analysis	North America (US and Canada) Europe (Germany, UK, France, Italy, Spain, and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and Rest of Middle East and Africa)
Antibody Cocktail Market Key Companies	Cipla Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Zydus Cadila, AstraZeneca, Aridis Pharmaceuticals Inc., Immunome Inc., Celltrion Healthcare Co., Ltd., and Eli Lilly and Company
Antibody Cocktail Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted

Segmentation of Global Antibody Cocktail Market-

Global Antibody Cocktail Market – By Types

Monovalent Antibody
Polyvalent Antibody

Global Antibody Cocktail Market – By Indication

COVID-19
Cancer
HIV

Global Antibody Cocktail Market – By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Antibody Cocktail Market – By Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Antibody Cocktails Market
2.2. Global Antibody Cocktails Market, By Type
2.3. Global Antibody Cocktails Market, By Indication
2.4. Global Antibody Cocktails Market, By Distribution Channel
2.5. Global Antibody Cocktails Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Antibody Cocktails Market Value, 2017-2030, (US$ Mn))
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Indication
3.5.3. Distribution Channel
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Type Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. COVID-19 Marketing
4.7.2. InCOVID-19 Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Antibody Cocktails Market
7.1. Global Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
7.1.1. Overview
7.1.2. Global Antibody Cocktails Market, By Type, 2022 vs 2030 (in%)
7.1.3. Global Antibody Cocktails Market, By Monovalent Antibody, 2017-2030 (US$ Mn))
7.1.4. Global Antibody Cocktails Market, By Polyvalent Antibody, 2017-2030 (US$ Mn))
7.2. Global Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
7.2.1. Overview
7.2.2. Global Antibody Cocktails Market, By Indication, 2022 vs 2030 (in%)
7.2.3. Global Antibody Cocktails Market, By COVID-19, 2017-2030 (US$ Mn))
7.2.4. Global Antibody Cocktails Market, By Cancer, 2017-2030 (US$ Mn))
7.2.5. Global Antibody Cocktails Market, By HIV, 2017-2030 (US$ Mn))
7.3. Global Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
7.3.1. Overview
7.3.2. Global Antibody Cocktails Market, By Distribution Channel, 2022 vs 2030 (in%)
7.3.3. Global Antibody Cocktails Market, By Hospital Pharmacies, 2017-2030 (US$ Mn))
7.3.4. Global Antibody Cocktails Market, By Retail Pharmacies, 2017-2030 (US$ Mn))
7.3.5. Global Antibody Cocktails Market, By Online Pharmacies, 2017-2030 (US$ Mn))

8. North America Antibody Cocktails Market Analysis
8.1. North America Antibody Cocktails Market, by Type, 2017-2030(US$ Mn))
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Antibody Cocktails Market, by Indication, 2017-2030(US$ Mn))
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Antibody Cocktails Market, by Distribution Channel, 2017-2030(US$ Mn))
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
8.4.1. U.S.
8.4.1.1. U.S. Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
8.4.1.2. U.S. Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
8.4.1.3. U.S. Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
8.4.1.4. U.S. Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
8.4.2. Canada
8.4.2.1. Canada Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
8.4.2.2. Canada Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
8.4.2.3. Canada Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
8.4.2.4. Canada Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))

9. Europe Antibody Cocktails Market Analysis
9.1. Europe Antibody Cocktails Market, by Type, 2017-2030(US$ Mn))
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Antibody Cocktails Market, by Indication, 2017-2030(US$ Mn))
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Antibody Cocktails Market, by Distribution Channel, 2017-2030(US$ Mn))
9.3.1. Overview
9.3.2. SRC Analysis

9.4. Europe Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
9.4.1. Germany
9.4.1.1. Germany Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.1.2. Germany Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
9.4.1.3. Germany Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
9.4.1.4. Germany Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.2. France
9.4.2.1. France Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.2.2. France Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
9.4.2.3. France Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
9.4.2.4. France Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.3. UK
9.4.3.1. UK Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.3.2. UK Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
9.4.3.3. UK Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
9.4.3.4. UK Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.4. Italy
9.4.4.1. Italy Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.4.2. Italy Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
9.4.4.3. Italy Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
9.4.4.4. Italy Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.5. Spain
9.4.5.1. Spain Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.5.2. Spain Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
9.4.5.3. Spain Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
9.4.5.4. Spain Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.6.2. Rest of Europe Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
9.4.6.3. Rest of Europe Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
9.4.6.4. Rest of Europe Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))

10. Asia Pacific Antibody Cocktails Market Analysis
10.1. Asia Pacific Antibody Cocktails Market, by Type, 2017-2030(US$ Mn))
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Antibody Cocktails Market, by Indication, 2017-2030(US$ Mn))
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Antibody Cocktails Market, by Distribution Channel, 2017-2030(US$ Mn))
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
10.4.1. China
10.4.1.1. China Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.1.2. China Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
10.4.1.3. China Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
10.4.1.4. China Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.2. Japan
10.4.2.1. Japan Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.2.2. Japan Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
10.4.2.3. Japan Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
10.4.2.4. Japan Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.3. India
10.4.3.1. India Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.3.2. India Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
10.4.3.3. India Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
10.4.3.4. India Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.4. South Korea
10.4.4.1. South Korea Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.4.2. South Korea Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
10.4.4.3. South Korea Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
10.4.4.4. South Korea Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.5. South-East Asia
10.4.5.1. South-East Asia Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.5.2. South-East Asia Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
10.4.5.3. South-East Asia Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
10.4.5.4. South-East Asia Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.6.2. Rest of Asia Pacific Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
10.4.6.3. Rest of Asia Pacific Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
10.4.6.4. Rest of Asia Pacific Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))

11. Latin America Antibody Cocktails Market Analysis
11.1. Latin America Antibody Cocktails Market, by Type, 2017-2030(US$ Mn))
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Antibody Cocktails Market, by Indication, 2017-2030(US$ Mn))
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Antibody Cocktails Market, by Distribution Channel, 2017-2030(US$ Mn))
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
11.4.1. Brazil
11.4.1.1. Brazil Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
11.4.1.2. Brazil Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
11.4.1.3. Brazil Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
11.4.1.4. Brazil Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
11.4.2. Mexico
11.4.2.1. Mexico Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
11.4.2.2. Mexico Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
11.4.2.3. Mexico Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
11.4.2.4. Mexico Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
11.4.3.2. Rest of Latin America Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
11.4.3.3. Rest of Latin America Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
11.4.3.4. Rest of Latin America Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))

12. Middle East and Africa Antibody Cocktails Market Analysis
12.1. Middle East and Africa Antibody Cocktails Market, by Type, 2017-2030(US$ Mn))
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Antibody Cocktails Market, by Indication, 2017-2030(US$ Mn))
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Antibody Cocktails Market, by Distribution Channel, 2017-2030(US$ Mn))
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
12.4.1. GCC Countries
12.4.1.1. GCC Countries Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
12.4.1.2. GCC Countries Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
12.4.1.3. GCC Countries Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
12.4.1.4. GCC Countries Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
12.4.2. South Africa
12.4.2.1. South Africa Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
12.4.2.2. South Africa Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
12.4.2.3. South Africa Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
12.4.2.4. South Africa Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Antibody Cocktails Market Estimates and Forecast, 2017-2030 (US$ Mn))
12.4.3.2. Rest of Middle East and Africa Antibody Cocktails, By Type, 2017-2030 (US$ Mn))
12.4.3.3. Rest of Middle East and Africa Antibody Cocktails, By Indication, 2017-2030 (US$ Mn))
12.4.3.4. Rest of Middle East and Africa Antibody Cocktails, By Distribution Channel, 2017-2030 (US$ Mn))

13. Company Profiles
13.1. Cipla Inc.
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. F. Hoffmann-La Roche Ltd
13.3. Regeneron Pharmaceuticals Inc.
13.4. Zydus Cadila
13.5. AstraZeneca
13.6. Aridis Pharmaceuticals Inc.
13.7. Immunome Inc.
13.8. Celltrion Healthcare Co., Ltd.
13.9. Eli Lilly and Company

List of Figures
FIG. 1 Global Antibody Cocktails Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Antibody Cocktails Market Segmentation
FIG. 4 Global Antibody Cocktails Market, by Type, 2022 (US$ Mn))
FIG. 5 Global Antibody Cocktails Market, by Indication, 2022 (US$ Mn))
FIG. 6 Global Antibody Cocktails Market, by Distribution Channel, 2022 (US$ Mn))
FIG. 7 Global Antibody Cocktails Market, by Geography, 2022 (US$ Mn))
FIG. 8 Attractive Investment Proposition, by Type, 2022
FIG. 9 Attractive Investment Proposition, by Indication, 2022
FIG. 10 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Antibody Cocktails Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Antibody Cocktails Market Manufacturers, 2022
FIG. 14 Global Antibody Cocktails Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 15 Global Antibody Cocktails Market, by Monovalent Antibody, Value, 2017-2030 (US$ Mn))
FIG. 16 Global Antibody Cocktails Market, by Polyvalent Antibody, Value, 2017-2030 (US$ Mn))
FIG. 17 Global Antibody Cocktails Market Value Contribution, By Indication, 2022 & 2030 (Value %)
FIG. 18 Global Antibody Cocktails Market, by COVID-19, Value, 2017-2030 (US$ Mn))
FIG. 19 Global Antibody Cocktails Market, by Cancer, 2017-2030 (US$ Mn))
FIG. 20 Global Antibody Cocktails Market, by HIV, 2017-2030 (US$ Mn))
FIG. 21 Global Antibody Cocktails Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 22 Global Antibody Cocktails Market, by Hospital Pharmacies, Value, 2017-2030 (US$ Mn))
FIG. 23 Global Antibody Cocktails Market, by Retail Pharmacies, 2017-2030 (US$ Mn))
FIG. 24 Global Antibody Cocktails Market, by Online Pharmacies, 2017-2030 (US$ Mn))
FIG. 25 North America Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 26 U.S. Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 27 Canada Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 28 Europe Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 29 Germany Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 30 France Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 31 U.K. Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 32 Italy Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 33 Spain Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 34 Rest of Europe Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 35 Asia Pacific Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 36 China Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 37 Japan Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 38 India Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 39 South Korea Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 40 South-East Asia Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 41 Rest of Asia Pacific Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 42 Latin America Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 43 Brazil Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 44 Mexico Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 45 Rest of Latin America Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 46 Middle East & Africa Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 47 GCC Countries Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 48 South Africa Antibody Cocktails Market, 2017-2030 (US$ Mn))
FIG. 49 Rest of Middle East and Africa Antibody Cocktails Market, 2017-2030 (US$ Mn))

List of Tables
TABLE 1 Market Snapshot: Global Antibody Cocktails Market
TABLE 2 Global Antibody Cocktails Market, by Competitive Benchmarking, 2022
TABLE 3 Global Antibody Cocktails Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Antibody Cocktails Market, by Key Strategies Analysis, 2022
TABLE 5 Global Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 6 Global Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 7 Global Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 8 Global Antibody Cocktails Market, by Geography, 2017-2030 (US$ Mn))
TABLE 9 North America Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 10 North America Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 11 North America Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 12 North America Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
TABLE 13 US Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 14 US Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 15 US Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 16 Canada Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 17 Canada Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 18 Canada Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 19 Europe Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 20 Europe Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 21 Europe Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 22 Europe Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
TABLE 23 Germany Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 24 Germany Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 25 Germany Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 26 France Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 27 France Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 28 France Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 29 UK Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 30 UK Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 31 UK Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 32 Italy Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 33 Italy Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 34 Italy Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 35 Spain Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 36 Spain Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 37 Spain Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 38 Rest of Europe Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 39 Rest of Europe Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 40 Rest of Europe Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 41 Asia Pacific Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 42 Asia Pacific Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 43 Asia Pacific Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 44 Asia Pacific Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
TABLE 45 China Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 46 China Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 47 China Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 48 Japan Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 49 Japan Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 50 Japan Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 51 India Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 52 India Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 53 India Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 54 South Korea Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 55 South Korea Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 56 South Korea Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 57 South-East Asia Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 58 South-East Asia Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 59 South-East Asia Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 60 Rest of Asia Pacific Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 61 Rest of Asia Pacific Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 62 Rest of Asia Pacific Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 63 Latin America Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 64 Latin America Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 65 Latin America Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 66 Latin America Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
TABLE 67 Brazil Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 68 Brazil Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 69 Brazil Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 70 Mexico Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 71 Mexico Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 72 Mexico Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 73 Rest of Latin America Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 74 Rest of Latin America Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 75 Rest of Latin America Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 76 Middle East and Africa Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 77 Middle East and Africa Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 78 Middle East and Africa Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 79 Middle East and Africa Antibody Cocktails Market, by Country, 2017-2030 (US$ Mn))
TABLE 80 GCC Countries Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 81 GCC Countries Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 82 GCC Countries Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 83 South Africa Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 84 South Africa Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 85 South Africa Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 86 Rest of Middle East and Africa Antibody Cocktails Market, by Type, 2017-2030 (US$ Mn))
TABLE 87 Rest of Middle East and Africa Antibody Cocktails Market, by Indication, 2017-2030 (US$ Mn))
TABLE 88 Rest of Middle East and Africa Antibody Cocktails Market, by Distribution Channel, 2017-2030 (US$ Mn))

Frequently asked questions

How does COVID-19 Impact the global Antibody Cocktail market?

The pandemic has positively impacted the global antibody cocktails market due to the increasing research and development activities conducted by the key players to develop antibody cocktails and lower the risk of hospitalization in the case of severely COVID-19-infected patients. This is because the pandemic has increased the number of people infected with COVID-19.

Which is the leading region of the market for Antibody Cocktail?

North America accounted for the most heightened share in the global antibody cocktail market.

What are the key drivers for the growth of the Antibody Cocktail market?

Rising number of COVID-19 cases and increasing prevalence of various cardiovascular disorders will contribute to the growth of the global antibody cocktail market.

Which is the major segment in the Antibody Cocktail market by type?

The monovalent antibody segment had a major share in the global market in 2022.

Which is the major segment in the Antibody Cocktail market by Indication?

The COVID-19 segment had a major share in the global market.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –